Subscribe

Thomas Willemsen

Articles by Thomas Willemsen

Thomas Willemsen

Targeting Hematological Malignancies With Autologous and Allogeneic Cell Therapies

ByThomas Willemsen

November 22nd 2022

Thomas Willemsen, president and chief executive officer, Tessa Therapeutics, discussed the company’s technologies and 2023 milestones.

Latest Updated Articles

Targeting Hematological Malignancies With Autologous and Allogeneic Cell Therapies
November 22nd 2022